The recent consensus conferences of the European Committee of Hyperbaric Medicine (ECHM) and the European Underwater and Baromedical Society (EUBS), which were held in April 2016, revalidated the following therapeutic recommendations:
To this list was added the treatment of sequelae of stroke, in certain conditions.
There are few randomized prospective studies about the effectiveness of hyperbaric oxygen therapy (HBOT). However, ten clinical indications are currently the subject of a type 1 (highly recommended) or type 2 (recommended) recommendation.
In Switzerland, TARMED currently recognizes five indications: